RxDoctor Payments Data

Dennis Teehan, MD

Preventive Medicine/Occupational Environmental Medicine · Dedham, MANPI 1306006945

Payments from drug & device makers

$7,534in general payments, 2019–2025

Across 400 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$896
  • Lilly USA, LLC$749
  • Pfizer$706
  • Amgen$595
  • Novartis$520
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$7,526100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few preventive medicine/occupational environmental medicine providers in Massachusettsto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$46,243
Medicare patients
99
Services billed
439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$75,249
TrulicityDulaglutide63$63,489
Nurtec OdtRimegepant Sulfate11$20,586
MounjaroTirzepatide18$20,114
EliquisApixaban17$19,467
Praluent PenAlirocumab11$5,553
BelbucaBuprenorphine Hcl11$5,258
Rosuvastatin Calcium71$1,872
Atorvastatin Calcium97$1,273
Metoprolol Succinate50$1,049
Losartan Potassium95$917
Albuterol Sulfate HfaAlbuterol Sulfate22$917
Levothyroxine Sodium35$693
Chlorthalidone23$643
Valsartan12$581

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$749$83,60381 claims
Novo NordiskOzempic$451$75,24972 claims
PfizerNurtec Odt, Eliquis$706$40,05328 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few preventive medicine/occupational environmental medicine providers in Massachusettson file to place this against a meaningful peer group, so we don't.

Other preventive medicine/occupational environmental medicine in Dedham

Where these figures come from

Is this you, or does something look wrong? →